Published in Bioconjug Chem on November 21, 2001
Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface. Angew Chem Int Ed Engl (2010) 1.17
Biological rationale for the design of polymeric anti-cancer nanomedicines. J Drug Target (2012) 0.93
Macromolecular therapeutics. J Control Release (2014) 0.87
Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid. Bioconjug Chem (2006) 0.83
Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review). Int J Oncol (2012) 0.82
The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells. AAPS PharmSci (2001) 0.82
Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines. Biomater Sci (2015) 0.82
N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers. Biomaterials (2011) 0.82
Design and development of effective siRNA delivery vehicles. Proc Natl Acad Sci U S A (2014) 0.77
Design of smart HPMA copolymer-based nanomedicines. J Control Release (2015) 0.76
Synthesis of Homopolymers and Copolymers Containing an Active Ester of Acrylic Acid by RAFT: Scaffolds for Controlling Polyvalent Ligand Display. J Polym Sci A Polym Chem (2008) 0.76
Functionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers. Nanoscale Res Lett (2016) 0.75
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med (1979) 2.48
Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29
Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet (1989) 2.12
HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur J Pharm Biopharm (2000) 2.05
Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci U S A (1990) 2.04
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults. Anesth Analg (1999) 1.85
Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 1.78
Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet (1992) 1.67
Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr (1985) 1.61
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res (1987) 1.60
Restoration of suppressor T-cell functions in children with AIDS following intravenous gamma globulin treatment. Am J Dis Child (1986) 1.58
Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child (1988) 1.54
Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet (1986) 1.51
Thrombocytopenia and human immunodeficiency virus in children. Pediatrics (1988) 1.49
Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.47
Clinical and immunologic effects of lipid-based parenteral nutrition in AIDS. JPEN J Parenter Enteral Nutr (1992) 1.46
Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis (1980) 1.45
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release (1998) 1.45
Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. JAMA (1991) 1.44
Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection. Pediatr Infect Dis J (1990) 1.40
False-negative N.B.T. tests due to transient malfunction of neutrophils. Lancet (1973) 1.40
Alkaline phosphatase band-10 fraction as a possible surrogate marker for human immunodeficiency virus type 1 infection in children. Arch Pathol Lab Med (1994) 1.39
Activated suppressor T cells in leprosy. J Immunol (1982) 1.37
Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro. Clin Exp Immunol (1978) 1.34
Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer (2000) 1.34
Pediatric AIDS. Curr Probl Pediatr (1986) 1.34
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release (1998) 1.33
Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur J Cancer (2001) 1.30
Soluble biomedical polymers. Polim Med (1977) 1.28
Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. J Biomed Mater Res (1989) 1.24
Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med (1994) 1.22
Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest (1992) 1.20
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol (1995) 1.18
AIDS: calcification of the basal ganglia in infants and children. Neurology (1986) 1.18
Pericarditis in familial Mediterranean fever. Am J Dis Child (1968) 1.17
Water soluble polymers in tumor targeted delivery. J Control Release (2001) 1.16
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med (1985) 1.15
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J Control Release (1999) 1.12
Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am J Obstet Gynecol (1996) 1.11
Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. J Clin Invest (1980) 1.10
Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex. J Pediatr (1986) 1.10
Bacterial infection in the acquired immunodeficiency syndrome of children. Pediatr Infect Dis (1985) 1.09
Immunological decay in thymectomized infants. Helv Paediatr Acta (1976) 1.08
Genetic affinities of Ethiopian Jews. Isr J Med Sci (1991) 1.08
Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res (1983) 1.07
Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings. Biomaterials (1990) 1.07
Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim Biophys Acta (1986) 1.04
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Autologous marrow reconstitutions in severe aplastic anaemia after ALG pretreatment and HL-A semi-incompatible bone marrow cell transfusion. Acta Haematol (1976) 1.04
Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol (1990) 1.03
Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers. Biochim Biophys Acta (1984) 1.03
Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol (1990) 1.02
Clinical comparison of frequency doubling technology perimetry and Humphrey perimetry. Br J Ophthalmol (2001) 1.01
Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am J Dis Child (1989) 1.01
Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis (1986) 1.01
Effect of two approaches to auditory training on speech recognition by hearing-impaired adults. J Speech Hear Res (1987) 1.01
Novel pH-sensitive hydrogels with adjustable swelling kinetics. Biomaterials (1998) 1.00
Hybrid hydrogels cross-linked by genetically engineered coiled-coil block proteins. Biomacromolecules (2001) 1.00
Immunohistochemical changes in morphologically involved and uninvolved colonic mucosa of patients with idiopathic proctitis. J Clin Invest (1977) 1.00
The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load. Am J Obstet Gynecol (1998) 0.99
Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharm Res (1999) 0.99
Long-term experience with poly(glycol monomethacrylate) gel in plastic operations of the nose. J Biomed Mater Res (1975) 0.98
In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes. N Engl J Med (1979) 0.98
The pharmacokinetics of polymer-bound adriamycin. Biochem Pharmacol (1990) 0.98
Controlled biodegradability of polymers--a key to drug delivery systems. Biomaterials (1984) 0.97
Polymerizable Fab' antibody fragments for targeting of anticancer drugs. Nat Biotechnol (1999) 0.97
Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. J Lipid Res (1985) 0.96
Successful bone-marrow transplantation in a lymphopenic immunologic deficiency syndrome. N Engl J Med (1971) 0.96
Three-dimensional image reconstruction of large nuclear RNP (lnRNP) particles by automated electron tomography. J Mol Biol (1997) 0.95
Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats. Pharm Res (2008) 0.95
A case of lymphogranuloma venereum of 20 years' duration. Isolation of Chlamydia trachomatis from perianal lesions. Br J Vener Dis (1980) 0.95
Detection of HIV in fetal central nervous system tissue. AIDS (1990) 0.95
Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection. Am J Dis Child (1986) 0.95
Maternofetal transmission of AIDS: frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis (1992) 0.95
Epidemiology of achalasia in central Israel. Rarity of esophageal cancer. Dig Dis Sci (1993) 0.95
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer (2004) 0.94
Phosphated crosslinked guar for colon-specific drug delivery. I. Preparation and physicochemical characterization. J Control Release (2000) 0.94
The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother (1982) 0.94
The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery. Pharm Res (1997) 0.94
L-cycloserine, an inhibitor of sphingolipid biosynthesis, inhibits HIV-1 cytopathic effects, replication, and infectivity. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.94
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J Drug Target (1996) 0.94
Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Clin Cancer Res (2000) 0.93
Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. Biochem Pharmacol (1989) 0.93
Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release (2001) 0.93